Published in Neurology on December 24, 2002
Deep brain stimulation for Parkinson's disease. Neurotherapeutics (2008) 1.53
Clinical and economic results of bilateral subthalamic nucleus stimulation in Parkinson's disease. J Neurol Neurosurg Psychiatry (2006) 1.05
Efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson's disease 4 years after surgery: double blind and open label evaluation. J Neurol Neurosurg Psychiatry (2004) 1.04
Deep brain stimulation in Parkinson's disease: meta-analysis of randomized controlled trials. J Neurol (2014) 0.99
Late-stage Parkinson disease. Nat Rev Neurol (2012) 0.97
The effect of deep brain stimulation on quality of life in movement disorders. J Neurol Neurosurg Psychiatry (2005) 0.94
Moving forward: advances in the treatment of movement disorders with deep brain stimulation. Front Integr Neurosci (2011) 0.94
Continuous levodopa for advanced Parkinson's disease. Neuropsychiatr Dis Treat (2007) 0.92
Only physical aspects of quality of life are significantly improved by bilateral subthalamic stimulation in Parkinson's disease. J Neurol (2005) 0.90
Influence of bilateral Stn-stimulation on psychiatric symptoms and psychosocial functioning in patients with Parkinson's disease. J Neural Transm (Vienna) (2005) 0.89
Long-term outcome of subthalamic nucleus deep brain stimulation for Parkinson's disease using an MRI-guided and MRI-verified approach. J Neurol Neurosurg Psychiatry (2014) 0.87
Different patterns of medication change after subthalamic or pallidal stimulation for Parkinson's disease: target related effect or selection bias? J Neurol Neurosurg Psychiatry (2005) 0.86
Effects of subthalamic nucleus stimulation on emotional prosody comprehension in Parkinson's disease. PLoS One (2011) 0.80
What is the best treatment for fluctuating Parkinson's disease: continuous drug delivery or deep brain stimulation of the subthalamic nucleus? J Neural Transm (Vienna) (2010) 0.79
Effects of five years of chronic STN stimulation on muscle strength and movement speed. Exp Brain Res (2010) 0.79
Functional correlates of the therapeutic and adverse effects evoked by thalamic stimulation for essential tremor. Brain (2016) 0.78
Neurosurgery in Parkinson's disease: Social adjustment, quality of life and coping strategies. Neural Regen Res (2013) 0.76
Depression and intelligence in patients with Parkinson's disease and deep-brain stimulation. J Natl Med Assoc (2006) 0.75
Health-related quality of life in segmental dystonia is improved by bilateral pallidal stimulation. J Neurol (2008) 0.75
High frequency deep brain stimulation of the subthalamic nucleus versus continuous subcutaneous apomorphine infusion therapy: a review. J Neural Transm (Vienna) (2010) 0.75
Neurostimulation for Parkinson's disease with early motor complications. N Engl J Med (2013) 6.37
Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med (2001) 6.07
Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. Lancet (2004) 5.06
Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med (1998) 4.72
Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain (2005) 4.33
Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet (1991) 3.89
Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders. J Neurosurg (1996) 3.37
Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl Neurophysiol (1987) 3.14
Predominant dystonia with marked cerebellar atrophy: a rare phenotype in familial dystonia. Neurology (2006) 3.07
Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet (1995) 3.06
Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog Neurobiol (2001) 2.45
Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease. J Neurol Neurosurg Psychiatry (2004) 2.21
Subthalamic deep brain stimulation at individualized frequencies for Parkinson disease. Neurology (2012) 2.18
The impact on Parkinson's disease of electrical parameter settings in STN stimulation. Neurology (2002) 2.14
Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers. Neurology (2012) 2.12
Y chromosome microdeletions and alterations of spermatogenesis. Endocr Rev (2001) 2.07
Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease. Brain (2009) 1.91
Predictors of effective bilateral subthalamic nucleus stimulation for PD. Neurology (2002) 1.89
Mutations within the MGC4607 gene cause cerebral cavernous malformations. Am J Hum Genet (2004) 1.88
Neuropsychological changes between "off" and "on" STN or GPi stimulation in Parkinson's disease. Neurology (2000) 1.85
The pathophysiology of tremor. Muscle Nerve (2001) 1.76
The impact of deep brain stimulation on executive function in Parkinson's disease. Brain (2000) 1.74
A multidisciplinary study of patients with early-onset PD with and without parkin mutations. Neurology (2008) 1.74
Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients. Brain (2008) 1.70
Acute and long-term effects of subthalamic nucleus stimulation in Parkinson's disease. Stereotact Funct Neurosurg (1994) 1.66
Involvement of the human pedunculopontine nucleus region in voluntary movements. Neurology (2010) 1.60
Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: a consecutive series of 62 patients. Ann Neurol (1999) 1.57
Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease. Brain (1998) 1.56
Study of physiological availability of temazepam in man. Int J Clin Pharmacol (1972) 1.49
Changes in cerebral activity pattern due to subthalamic nucleus or internal pallidum stimulation in Parkinson's disease. Ann Neurol (1997) 1.48
The core assessment program for intracerebral transplantation. Mov Disord (1995) 1.47
Long-term electrical inhibition of deep brain targets in movement disorders. Mov Disord (1998) 1.47
Responses of substantia nigra pars reticulata and globus pallidus complex to high frequency stimulation of the subthalamic nucleus in rats: electrophysiological data. Neurosci Lett (1995) 1.43
Inhibition of levodopa effects by internal pallidal stimulation. Mov Disord (1998) 1.42
Effect of high-frequency stimulation of the subthalamic nucleus on the neuronal activities of the substantia nigra pars reticulata and ventrolateral nucleus of the thalamus in the rat. Neuroscience (2000) 1.41
[Effects of the stimulation of the subthalamic nucleus in Parkinson disease]. Rev Neurol (Paris) (1993) 1.39
Clinical characteristics and topography of lesions in movement disorders due to thalamic lesions. Neurology (2001) 1.39
Bilateral subthalamic nucleus stimulation for severe Parkinson's disease. Mov Disord (1995) 1.28
Mirthful laughter induced by subthalamic nucleus stimulation. Mov Disord (2001) 1.27
Bromocriptine associated with a peripheral dopamine blocking agent in treatment of Parkinson's disease. Lancet (1979) 1.27
Deletion and expression analysis of AZFa genes on the human Y chromosome revealed a major role for DBY in male infertility. Hum Mol Genet (2000) 1.27
Laboratory guidelines for molecular diagnosis of Y-chromosomal microdeletions. Int J Androl (1999) 1.27
Metabolism and aerobic capacity of skeletal muscle in chronic respiratory failure related to chronic obstructive pulmonary disease. Eur Respir J (1992) 1.24
Effect of chronic bilateral subthalamic nucleus (STN) stimulation on postural control in Parkinson's disease. Brain (2003) 1.23
Opposite motor effects of pallidal stimulation in Parkinson's disease. Ann Neurol (1998) 1.23
High frequency of well-defined Y-chromosome deletions in idiopathic Sertoli cell-only syndrome. Hum Reprod (1998) 1.20
Deep brain stimulation in the treatment of severe dystonia. J Neurol (2001) 1.19
Chronic VIM thalamic stimulation in Parkinson's disease, essential tremor and extra-pyramidal dyskinesias. Acta Neurochir Suppl (Wien) (1993) 1.18
Treatment of tremor in Parkinson's disease by subthalamic nucleus stimulation. Mov Disord (1998) 1.17
Subcutaneous apomorphine in Parkinson's disease. J Neurol Neurosurg Psychiatry (1989) 1.16
Clinical neurophysiology of tremor. J Clin Neurophysiol (1996) 1.16
Deep brain stimulation of the subthalamic nucleus for Parkinson's disease: methodologic aspects and clinical criteria. Neurology (2000) 1.16
Long-term outcome of bilateral pallidal deep brain stimulation for primary cervical dystonia. Neurology (2007) 1.14
Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from Founder effects. Am J Hum Genet (2001) 1.13
Subthalamic nucleus, sensorimotor cortex and muscle interrelationships in Parkinson's disease. Brain (2001) 1.13
Pyramidal tract side effects induced by deep brain stimulation of the subthalamic nucleus. J Neurol Neurosurg Psychiatry (2007) 1.12
EGF receptor amplification and expression in human brain tumours. Eur J Cancer (1992) 1.12
Effect of bilateral subthalamic nucleus stimulation on gait in Parkinson's disease. Brain (2001) 1.11
Multicentre European study of thalamic stimulation for parkinsonian tremor: a 6 year follow-up. J Neurol Neurosurg Psychiatry (2007) 1.11
Stimulation of the ventral intermediate thalamic nucleus in tremor dominated Parkinson's disease and essential tremor. Acta Neurochir (Wien) (1995) 1.11
The pathophysiology of parkinsonian tremor: a review. J Neurol (2000) 1.10
Striatal dopamine deficiency in Parkinson's disease: role of aging. Ann Neurol (1989) 1.09
Wnt activation promotes neuronal differentiation of glioblastoma. Cell Death Dis (2013) 1.08